ID   ST32C_HUMAN             Reviewed;         486 AA.
AC   Q86UX6; Q5T0Q5; Q86UE1;
DT   18-APR-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   12-OCT-2022, entry version 162.
DE   RecName: Full=Serine/threonine-protein kinase 32C;
DE            EC=2.7.11.1;
DE   AltName: Full=PKE;
DE   AltName: Full=Yet another novel kinase 3;
GN   Name=STK32C {ECO:0000312|EMBL:AAH45760.1}; Synonyms=YANK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAM21719.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Ma A.-H., Nelson D.A., Xia L., Ravi L., Chen H.-C., Robinson D.R.,
RA   Kung H.-J.;
RT   "PKE, a new human AGC group kinase, phosphorylates SET, a PP2A inhibitor.";
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000312|EMBL:AL512622}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAH45760.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT ALA-334.
RC   TISSUE=Testis {ECO:0000312|EMBL:AAH45760.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4] {ECO:0000305}
RP   NOMENCLATURE.
RX   PubMed=12471243; DOI=10.1126/science.1075762;
RA   Manning G., Whyte D.B., Martinez R., Hunter T., Sudarsanam S.;
RT   "The protein kinase complement of the human genome.";
RL   Science 298:1912-1934(2002).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-15 AND SER-18, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7]
RP   VARIANT [LARGE SCALE ANALYSIS] HIS-376.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
RN   [8]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-454 AND LYS-467.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [9]
RP   VARIANT LEU-151.
RX   PubMed=28940097; DOI=10.1007/s00439-017-1843-2;
RA   Anazi S., Maddirevula S., Salpietro V., Asi Y.T., Alsahli S., Alhashem A.,
RA   Shamseldin H.E., AlZahrani F., Patel N., Ibrahim N., Abdulwahab F.M.,
RA   Hashem M., Alhashmi N., Al Murshedi F., Al Kindy A., Alshaer A.,
RA   Rumayyan A., Al Tala S., Kurdi W., Alsaman A., Alasmari A., Banu S.,
RA   Sultan T., Saleh M.M., Alkuraya H., Salih M.A., Aldhalaan H., Ben-Omran T.,
RA   Al Musafri F., Ali R., Suleiman J., Tabarki B., El-Hattab A.W., Bupp C.,
RA   Alfadhel M., Al Tassan N., Monies D., Arold S.T., Abouelhoda M.,
RA   Lashley T., Houlden H., Faqeih E., Alkuraya F.S.;
RT   "Expanding the genetic heterogeneity of intellectual disability.";
RL   Hum. Genet. 136:1419-1429(2017).
RN   [10]
RP   ERRATUM OF PUBMED:28940097.
RX   PubMed=29288388; DOI=10.1007/s00439-017-1859-7;
RA   Anazi S., Maddirevula S., Salpietro V., Asi Y.T., Alsahli S., Alhashem A.,
RA   Shamseldin H.E., AlZahrani F., Patel N., Ibrahim N., Abdulwahab F.M.,
RA   Hashem M., Alhashmi N., Al Murshedi F., Al Kindy A., Alshaer A.,
RA   Rumayyan A., Al Tala S., Kurdi W., Alsaman A., Alasmari A., Banu S.,
RA   Sultan T., Saleh M.M., Alkuraya H., Salih M.A., Aldhalaan H., Ben-Omran T.,
RA   Al Musafri F., Ali R., Suleiman J., Tabarki B., El-Hattab A.W., Bupp C.,
RA   Alfadhel M., Al Tassan N., Monies D., Arold S.T., Abouelhoda M.,
RA   Lashley T., Houlden H., Faqeih E., Alkuraya F.S.;
RT   "Correction to: Expanding the genetic heterogeneity of intellectual
RT   disability.";
RL   Hum. Genet. 137:105-109(2018).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000250|UniProtKB:Q60592};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000250|UniProtKB:Q60592};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q60592};
CC   -!- INTERACTION:
CC       Q86UX6; O14964: HGS; NbExp=3; IntAct=EBI-1050045, EBI-740220;
CC       Q86UX6; P08238: HSP90AB1; NbExp=2; IntAct=EBI-1050045, EBI-352572;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q86UX6-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:15489334};
CC         IsoId=Q86UX6-2; Sequence=VSP_051998;
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein
CC       kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY098866; AAM21719.1; -; mRNA.
DR   EMBL; AL512622; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL590105; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC045760; AAH45760.1; -; mRNA.
DR   CCDS; CCDS7666.1; -. [Q86UX6-1]
DR   CCDS; CCDS81525.1; -. [Q86UX6-2]
DR   RefSeq; NP_001305808.1; NM_001318879.1. [Q86UX6-2]
DR   RefSeq; NP_775846.2; NM_173575.3. [Q86UX6-1]
DR   RefSeq; XP_011537995.1; XM_011539693.2. [Q86UX6-2]
DR   RefSeq; XP_011537996.1; XM_011539694.1. [Q86UX6-2]
DR   RefSeq; XP_011537997.1; XM_011539695.1. [Q86UX6-2]
DR   RefSeq; XP_011537998.1; XM_011539696.1. [Q86UX6-2]
DR   AlphaFoldDB; Q86UX6; -.
DR   SMR; Q86UX6; -.
DR   BioGRID; 129429; 23.
DR   IntAct; Q86UX6; 72.
DR   MINT; Q86UX6; -.
DR   STRING; 9606.ENSP00000298630; -.
DR   BindingDB; Q86UX6; -.
DR   ChEMBL; CHEMBL5405; -.
DR   iPTMnet; Q86UX6; -.
DR   PhosphoSitePlus; Q86UX6; -.
DR   BioMuta; STK32C; -.
DR   DMDM; 74762451; -.
DR   EPD; Q86UX6; -.
DR   jPOST; Q86UX6; -.
DR   MassIVE; Q86UX6; -.
DR   MaxQB; Q86UX6; -.
DR   PaxDb; Q86UX6; -.
DR   PeptideAtlas; Q86UX6; -.
DR   PRIDE; Q86UX6; -.
DR   ProteomicsDB; 69930; -. [Q86UX6-1]
DR   ProteomicsDB; 69931; -. [Q86UX6-2]
DR   Antibodypedia; 19318; 142 antibodies from 28 providers.
DR   DNASU; 282974; -.
DR   Ensembl; ENST00000298630.8; ENSP00000298630.3; ENSG00000165752.17. [Q86UX6-1]
DR   Ensembl; ENST00000368622.5; ENSP00000357611.1; ENSG00000165752.17. [Q86UX6-2]
DR   GeneID; 282974; -.
DR   KEGG; hsa:282974; -.
DR   MANE-Select; ENST00000298630.8; ENSP00000298630.3; NM_173575.4; NP_775846.2.
DR   UCSC; uc001lld.2; human. [Q86UX6-1]
DR   CTD; 282974; -.
DR   DisGeNET; 282974; -.
DR   GeneCards; STK32C; -.
DR   HGNC; HGNC:21332; STK32C.
DR   HPA; ENSG00000165752; Tissue enhanced (testis).
DR   neXtProt; NX_Q86UX6; -.
DR   OpenTargets; ENSG00000165752; -.
DR   PharmGKB; PA134888050; -.
DR   VEuPathDB; HostDB:ENSG00000165752; -.
DR   eggNOG; KOG0598; Eukaryota.
DR   GeneTree; ENSGT00940000160573; -.
DR   HOGENOM; CLU_000288_63_5_1; -.
DR   InParanoid; Q86UX6; -.
DR   OMA; MHRRSYY; -.
DR   OrthoDB; 668916at2759; -.
DR   PhylomeDB; Q86UX6; -.
DR   TreeFam; TF313395; -.
DR   PathwayCommons; Q86UX6; -.
DR   SignaLink; Q86UX6; -.
DR   BioGRID-ORCS; 282974; 9 hits in 1074 CRISPR screens.
DR   ChiTaRS; STK32C; human.
DR   GenomeRNAi; 282974; -.
DR   Pharos; Q86UX6; Tbio.
DR   PRO; PR:Q86UX6; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; Q86UX6; protein.
DR   Bgee; ENSG00000165752; Expressed in right testis and 130 other tissues.
DR   ExpressionAtlas; Q86UX6; baseline and differential.
DR   Genevisible; Q86UX6; HS.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Kinase; Magnesium; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..486
FT                   /note="Serine/threonine-protein kinase 32C"
FT                   /id="PRO_0000232415"
FT   DOMAIN          93..353
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..56
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          396..419
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          444..486
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        19..39
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        444..469
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        216
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:Q60592,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-
FT                   ProRule:PRU10027"
FT   BINDING         99..107
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q60592,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         122
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q60592,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         10
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8QZV4"
FT   MOD_RES         15
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         18
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..117
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_051998"
FT   VARIANT         151
FT                   /note="V -> L (found in a patient with global developmental
FT                   delay; unknown pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:28940097"
FT                   /id="VAR_084657"
FT   VARIANT         334
FT                   /note="T -> A (in dbSNP:rs17854384)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_025900"
FT   VARIANT         376
FT                   /note="R -> H (in a colorectal cancer sample; somatic
FT                   mutation; dbSNP:rs764558009)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035637"
FT   VARIANT         454
FT                   /note="A -> T (in dbSNP:rs56109103)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041170"
FT   VARIANT         467
FT                   /note="E -> K (in dbSNP:rs55812591)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041171"
SQ   SEQUENCE   486 AA;  54994 MW;  38FEFBB3863B21F3 CRC64;
     MRSGAERRGS SAAASPGSPP PGRARPAGSD APSALPPPAA GQPRARDSGD VRSQPRPLFQ
     WSKWKKRMGS SMSAATARRP VFDDKEDVNF DHFQILRAIG KGSFGKVCIV QKRDTEKMYA
     MKYMNKQQCI ERDEVRNVFR ELEILQEIEH VFLVNLWYSF QDEEDMFMVV DLLLGGDLRY
     HLQQNVQFSE DTVRLYICEM ALALDYLRGQ HIIHRDVKPD NILLDERGHA HLTDFNIATI
     IKDGERATAL AGTKPYMAPE IFHSFVNGGT GYSFEVDWWS VGVMAYELLR GWRPYDIHSS
     NAVESLVQLF STVSVQYVPT WSKEMVALLR KLLTVNPEHR LSSLQDVQAA PALAGVLWDH
     LSEKRVEPGF VPNKGRLHCD PTFELEEMIL ESRPLHKKKK RLAKNKSRDN SRDSSQSEND
     YLQDCLDAIQ QDFVIFNREK LKRSQDLPRE PLPAPESRDA AEPVEDEAER SALPMCGPIC
     PSAGSG
//
